It's out of the ACCC's hands now. I expect the Court will side with TPM. Not sure exactly what that means for the share price but I'm a long term bull on TPM.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%